Vernaza et al. found that knocking down CDKN3 reduced the expression of the cell proliferation markers Ki67 and proliferating cell nuclear antigen (PCNA), a binding partner of PCLAF, and decreased the colony formation of NB cells (Vernaza et al., 2024). The gene discussed is CDKN3; the disease is neuroblastoma.